Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cerelixis developing precision crop protection products that optimize plant growth & improve resilience to adverse environmental conditions.
MyoPax creates advanced regenerative stem cell therapies to combat the devasting effects of muscle illnesses.
Enduro Genetics is a technology provider committed to enabling large-scale fermentations.
Visibuilt is to pioneer sustainable road-building solutions by replacing standard asphalt with cutting-edge, environmentally materials.
Commit Biologics is a biotechnology research company developing a novel immunotherapy platform for the treatment of cancer.
Proteomics, AI, SaaS, biotech, diagnostics
Veil.ai offers health data anonymization, synthetic data and pseudonymization services.
Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia.
Sundew is a biotechnology company that provides biological services for the treatment of aquatic pests and diseases.
NorFalk is a biotech company that produces bio-based, sustainable surfactants for applications in consumer everyday products.
FÆRM is a food technology company.
Pharmista Technologies is on a mission to revolutionize women’s health by disrupting the pregnancy testing market.
SQALE offers precision fermentation and microalgae businesses Bioprocess Optimization as a service.
PreTT is revolutionizing the treatment of cancer by using sophisticated radioligand therapies that outperform conventional techniques.
Polyceutix transforms cancer treatment by unleashing the full power of the immune system.
SNL Biosolutions created a technological platform to decrease deforestation and manufacture fermented-based oils on a large scale.
SymbioMatch mission is to grow healthier plants using AI for tailored biostimulants with less fertilizers used.
Oasicare creates medical devices to help prevent severe perineal tears and OASI during vaginal childbirth.
FimmCyte is a biotechnology company that engages in the research and treatment of chronic endometriosis disease.
First-in-class hardware-and-software-as-a-service diagnostics for the 400M suffering from middle ear problems
Notify Therapeutics develops therapies for the treatment of infertility.
Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.
TriptoBIO is a biotechnology research company developing a platform for producing natural plant compounds.
Amalus Therapeutics' objective is to significantly improve the lives of those suffering from cancer and fibrotic disorders
BioInnovation Institute has invested in 141 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioInnovation Institute's top investment sectors include Biotechnology, Medical, Health Care, Life Science, Therapeutics. The firm invests across 31 different industry categories.
Among tracked funding rounds, Enduro Genetics received $12.4M in a Series A round. BioInnovation Institute's total known invested capital is $314.9M.
BioInnovation Institute's average investment size is $4.0M across its portfolio of 141 companies.
Recent BioInnovation Institute portfolio additions include Cerelixis, MyoPax, Enduro Genetics, Visibuilt, Commit Biologics. These companies were founded in 2020 or later.